Pular para o conteúdo principal
Ranking Invest

PEN - Penumbra, Inc.

Segmento: HealthcarePenumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovascular lesions under the Penumbra Coil 400, POD400, PAC400, and Penumbra SMART Coil brand names; and neurovascular access systems designed to provide intracranial access for use in a range of neurovascular therapies under the Neuron, Neuron MAX, Select, BENCHMARK, BMX96, DDC, and PX SLIM brands. It also provides neurosurgical aspiration tools for the removal of tissue and fluids under the Artemis Neuro Evacuation Device brand; aspiration-based thrombectomy systems for vascular applications under the Indigo System brand; and detachable embolic coil systems for peripheral embolization under the Ruby Coil and Ruby LP brand names. In addition, the company offers microcatheter for the delivery of detachable coils and occlusion devices under the LANTERN brand; and detachable, microcatheter-deliverable occlusion devices designed primarily to occlude peripheral vessels under the POD (Penumbra Occlusion Device) brand, as well as immersive computer-based technologies and immersive therapeutics to promote health, motor function, and cognition under the Real Immersive System brand; and a complementary device for use with Ruby Coil and POD for vessel occlusion under the Packing Coil and Packing Coil LP brands. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Análise Ranking Invest

Valuation estimado
$ 1.88 Bi
Valor de Mercado
$ 12.52 Bi
Sobrepreço (AV)+564.7%
IVR
0.15A companhia vale 0,15 vezes o seu valor de mercado atual de acordo com a estimativa do Ranking Invest.
IVR2
0.03O valuation alternativo equivale a 3% do valor de mercado da companhia.
MLL
0.03O lucro líquido dos controladores em 16 trimestres equivale a 3% do valor de mercado.
Último Balanço Atualizado: 2T2026

O Ranking Invest utiliza metodologia própria baseada em dados financeiros objetivos, considerando patrimônio, lucratividade e endividamento para estimar o valuation das empresas.

Dados da Empresa

Patrimônio Líquido

$ 1.53 Bi

Dívida Líquida

-$ 205.27 Mi

L4T

$ 160.59 Mi

MM4T

10.71%

Indicadores Básicos

ROE

10.49%

Índices de Previsibilidade

Receita Líquida

A0.02

Lucro

C0.43

Margem

C0.45

Índices de Tendência

Receita Líquida

A11.75

Lucro

A9.43

Margem

B7.65

Índices de Endividamento

DIV/PAT

-0.13

DIV/L4T

-1.28

Dívidas
Cotação
Gráfico Lucro/Receita Líquida X TrimestrePor padrão são exibidos os últimos 16 trimestres; quando houver mais trimestres disponíveis, use o botão junto à tabela de resultados para expandir o histórico.